The Potential of Exosomes for Osteoporosis Treatment: A Review

References

• Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164:1226–1232. doi:10.1016/j.cell.2016.01.043
   PubMed Web of Science ®Google Scholar
• Baek G, Choi H, Kim Y, Lee HC, Choi C. Mesenchymal stem cell-derived extracellular vesicles as therapeutics and as a drug delivery platform. Stem Cells Transl Med. 2019;8:880–886. doi:10.1002/sctm.18-0226
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19. doi:10.1186/s13578-019-0282-2
   PubMed Web of Science ®Google Scholar
• Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21:R125–134. doi:10.1093/hmg/dds317
   PubMed Web of Science ®Google Scholar
• Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118:1917–1950. doi:10.1021/acs.chemrev.7b00534
   PubMed Web of Science ®Google Scholar
• Trams EG, Lauter CJ, Salem N, Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta. 1981;645:63–70. doi:10.1016/0005-2736(81)90512-5
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412–9420. doi:10.1016/S0021-9258(18)48095-7
   PubMed Web of Science ®Google Scholar
• He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8:237–255. doi:10.7150/thno.21945
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang W, Ren X, Tu C, Li Z. Exosomes: a friend or foe for osteoporotic fracture? Front Endocrinol. 2021;12:679914. doi:10.3389/fendo.2021.679914
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367. doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Ferguson SW, Nguyen J. Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity. J Control Release. 2016;228:179–190. doi:10.1016/j.jconrel.2016.02.037
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Lv Q, Li X. Exosomes: from garbage bins to translational medicine. Int J Pharm. 2020;583:119333. doi:10.1016/j.ijpharm.2020.119333
   PubMedGoogle Scholar
• Simons M, Raposo G. Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21:575–581. doi:10.1016/j.ceb.2009.03.007
   PubMed Web of Science ®Google Scholar
• S ELA, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347–357. doi:10.1038/nrd3978
   PubMed Web of Science ®Google Scholar
• Katsimbri P. The biology of normal bone remodelling. Eur J Cancer Care. 2017;2017:26.
   Google Scholar
• Lane JM, Russell L, Khan SN. Osteoporosis. Clin Orthop Relat Res. 2000;139–150. doi:10.1097/00003086-200003000-00016
   PubMed Web of Science ®Google Scholar
• Meng F, Xue X, Yin Z, Gao F, Wang X, Geng Z. Research progress of exosomes in bone diseases: mechanism, diagnosis and therapy. Front Bioeng Biotechnol. 2022;10:866627. doi:10.3389/fbioe.2022.866627
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin Q, Zhang H, et al. M2 macrophage-derived exosomes promote diabetic fracture healing by acting as an immunomodulator. Bioact Mater. 2023;28:273–283. doi:10.1016/j.bioactmat.2023.05.018
   PubMed Web of Science ®Google Scholar
• Seeman E. Bone modeling and remodeling. Crit Rev Eukaryot Gene Expr. 2009;19:219–233. doi:10.1615/CritRevEukarGeneExpr.v19.i3.40
   PubMed Web of Science ®Google Scholar
• Lee JY, Yang JY, Kim SW. Bone lining cells could be sources of bone marrow adipocytes. Front Endocrinol. 2021;12:766254. doi:10.3389/fendo.2021.766254
   PubMed Web of Science ®Google Scholar
• Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000;289:1501–1504. doi:10.1126/science.289.5484.1501
   PubMed Web of Science ®Google Scholar
• Bar‐Shavit Z. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem. 2007;102(5):1130–1139. doi:10.1002/jcb.21553
   PubMed Web of Science ®Google Scholar
• Ono T, Hayashi M, Sasaki F, Nakashima T. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020;40:2. doi:10.1186/s41232-019-0111-3
   PubMed Web of Science ®Google Scholar
• Quinn JM, Gillespie MT. Modulation of osteoclast formation. Biochem Biophys Res Commun. 2005;328:739–745. doi:10.1016/j.bbrc.2004.11.076
   PubMed Web of Science ®Google Scholar
• Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr. 2009;19:109–124. doi:10.1615/CritRevEukarGeneExpr.v19.i2.20
   PubMed Web of Science ®Google Scholar
• Sadat-Ali M, Al-Dakheel DA, Al-Turki HA, Acharya S. Efficacy of autologous bone marrow derived Mesenchymal stem cells (MSCs), osteoblasts and osteoblasts derived exosome in the reversal of ovariectomy (OVX) induced osteoporosis in rabbit model. Am J Transl Res. 2021;13:6175–6181.
   PubMed Web of Science ®Google Scholar
• Luo ZW, Li FX, Liu YW, et al. Aptamer-functionalized exosomes from bone marrow stromal cells target bone to promote bone regeneration. Nanoscale. 2019;11:20884–20892. doi:10.1039/C9NR02791B
   PubMed Web of Science ®Google Scholar
• Zhao P, Xiao L, Peng J, Qian YQ, Huang CC. Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway. Eur Rev Med Pharmacol Sci. 2018;22:3962–3970. doi:10.26355/eurrev_201806_15280
   PubMed Web of Science ®Google Scholar
• Xie Y, Hu JH, Wu H, Huang ZZ, Yan HW, Shi ZY. Bone marrow stem cells derived exosomes improve osteoporosis by promoting osteoblast proliferation and inhibiting cell apoptosis. Eur Rev Med Pharmacol Sci. 2019;23:1214–1220. doi:10.26355/eurrev_201902_17014
   PubMed Web of Science ®Google Scholar
• Wang J, Fu M, He S, Cai P, Xiang X, Fang L. Expression profile analysis of lncRNA in bone marrow mesenchymal stem cells exosomes of postmenopausal osteoporosis patients through microarray and bioinformatics analyses. Pathol Res Pract. 2022;236:153985. doi:10.1016/j.prp.2022.153985
   PubMed Web of Science ®Google Scholar
• Fu M, Fang L, Xiang X, Fan X, Wu J, Wang J. Microarray analysis of circRNAs sequencing profile in exosomes derived from bone marrow mesenchymal stem cells in postmenopausal osteoporosis patients. J Clin Lab Anal. 2022;36:e23916. doi:10.1002/jcla.23916
   PubMed Web of Science ®Google Scholar
• Yang X, Yang J, Lei P, Wen T. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging. 2019;11:8777–8791. doi:10.18632/aging.102264
   PubMedGoogle Scholar
• You M, Ai Z, Zeng J, Fu Y, Zhang L, Wu X. Bone mesenchymal stem cells (BMSCs)-derived exosomal microRNA-21-5p regulates Kruppel-like factor 3 (KLF3) to promote osteoblast proliferation in vitro. Bioengineered. 2022;13:11933–11944. doi:10.1080/21655979.2022.2067286
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cao X, Li P, et al. microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats. Life Sci. 2021;272:119204. doi:10.1016/j.lfs.2021.119204
   PubMed Web of Science ®Google Scholar
• Jiang LB, Tian L, Zhang CG. Bone marrow stem cells-derived exosomes extracted from osteoporosis patients inhibit osteogenesis via microRNA-21/SMAD7. Eur Rev Med Pharmacol Sci. 2018;22:6221–6229. doi:10.26355/eurrev_201810_16028
   PubMed Web of Science ®Google Scholar
• Wei Y, Ma H, Zhou H, et al. miR-424-5p shuttled by bone marrow stem cells-derived exosomes attenuates osteogenesis via regulating WIF1-mediated Wnt/β-catenin axis. Aging. 2021;13:17190–17201. doi:10.18632/aging.203169
   PubMedGoogle Scholar
• Yang K, Li C, Lu S, et al. Exosomes from bone marrow mesenchymal stem cells promoted osteogenic differentiation by delivering miR-196a that targeted Dickkopf-1 to activate Wnt/β-catenin pathway. Bioengineered. 2021;12:6115–6133. doi:10.1080/21655979.2021.1972644
   PubMedGoogle Scholar
• Li L, Zhou X, Zhang JT, et al. Exosomal miR-186 derived from BMSCs promote osteogenesis through hippo signaling pathway in postmenopausal osteoporosis. J Orthop Surg Res. 2021;16:23. doi:10.1186/s13018-020-02160-0
   PubMed Web of Science ®Google Scholar
• Wang N, Liu X, Tang Z, et al. Increased BMSC exosomal miR-140-3p alleviates bone degradation and promotes bone restoration by targeting Plxnb1 in diabetic rats. J Nanobiotechnology. 2022;20:97. doi:10.1186/s12951-022-01267-2
   PubMed Web of Science ®Google Scholar
• Lu GD, Cheng P, Liu T, Wang Z. BMSC-derived exosomal miR-29a promotes angiogenesis and osteogenesis. Front Cell Dev Biol. 2020;8:608521. doi:10.3389/fcell.2020.608521
   PubMed Web of Science ®Google Scholar
• Wang X, Li X, Li J, et al. Mechanical loading stimulates bone angiogenesis through enhancing type H vessel formation and downregulating exosomal miR-214-3p from bone marrow-derived mesenchymal stem cells. FASEB J. 2021;35:e21150. doi:10.1096/fj.202001080RR
   PubMed Web of Science ®Google Scholar
• Tong X, Chen X, Zhang S, et al. The effect of exercise on the prevention of osteoporosis and bone angiogenesis. Biomed Res Int. 2019;2019:8171897. doi:10.1155/2019/8171897
   PubMed Web of Science ®Google Scholar
• Teng Z, Zhu Y, Zhang X, Teng Y, Lu S. Osteoporosis is characterized by altered expression of exosomal long non-coding RNAs. Front Genet. 2020;11:566959. doi:10.3389/fgene.2020.566959
   PubMed Web of Science ®Google Scholar
• Yang Y, Miao L, Chang S, et al. Exosome-Derived LncRNA TCONS_00072128 mediated osteogenic differentiation and inflammation by caspase 8 regulation. Front Genet. 2021;12:831420. doi:10.3389/fgene.2021.831420
   PubMed Web of Science ®Google Scholar
• Shi H, Jiang X, Xu C, Cheng Q. MicroRNAs in serum exosomes as circulating biomarkers for postmenopausal osteoporosis. Front Endocrinol. 2022;13:819056. doi:10.3389/fendo.2022.819056
   PubMed Web of Science ®Google Scholar
• Kong D, Chen T, Zheng X, Yang T, Zhang Y, Shao J. Comparative profile of exosomal microRNAs in postmenopausal women with various bone mineral densities by small RNA sequencing. Genomics. 2021;113:1514–1521. doi:10.1016/j.ygeno.2021.03.028
   PubMed Web of Science ®Google Scholar
• Chen M, Li Y, Lv H, Yin P, Zhang L, Tang P. Quantitative proteomics and reverse engineer analysis identified plasma exosome derived protein markers related to osteoporosis. J Proteomics. 2020;228:103940. doi:10.1016/j.jprot.2020.103940
   PubMed Web of Science ®Google Scholar
• Dong Q, Han Z, Tian L. Identification of serum exosome-derived circRNA-miRNA-TF-mRNA regulatory network in postmenopausal osteoporosis using bioinformatics analysis and validation in peripheral blood-derived mononuclear cells. Front Endocrinol. 2022;13:899503. doi:10.3389/fendo.2022.899503
   PubMed Web of Science ®Google Scholar
• Xie Y, Gao Y, Zhang L, Chen Y, Ge W, Tang P. Involvement of serum-derived exosomes of elderly patients with bone loss in failure of bone remodeling via alteration of exosomal bone-related proteins. Aging Cell. 2018;17:e12758. doi:10.1111/acel.12758
   PubMed Web of Science ®Google Scholar
• Xun J, Li C, Liu M, et al. Serum exosomes from young rats improve the reduced osteogenic differentiation of BMSCs in aged rats with osteoporosis after fatigue loading in vivo. Stem Cell Res Ther. 2021;12:424. doi:10.1186/s13287-021-02449-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Wang K, et al. Circulating exosomes from mice with LPS-induced bone loss inhibit osteoblast differentiation. Calcif Tissue Int. 2022;111:185–195. doi:10.1007/s00223-022-00977-x
   PubMed Web of Science ®Google Scholar
• Yahao G, Xinjia W. The role and mechanism of exosomes from umbilical cord mesenchymal stem cells in inducing osteogenesis and preventing osteoporosis. Cell Transplant. 2021;30:9636897211057465. doi:10.1177/09636897211057465
   Web of Science ®Google Scholar
• Yang BC, Kuang MJ, Kang JY, Zhao J, Ma JX, Ma XL. Human umbilical cord mesenchymal stem cell-derived exosomes act via the miR-1263/Mob1/Hippo signaling pathway to prevent apoptosis in disuse osteoporosis. Biochem Biophys Res Commun. 2020;524:883–889. doi:10.1016/j.bbrc.2020.02.001
   PubMed Web of Science ®Google Scholar
• Wang SZ, Jia J, Chen CH. lncRNA-KCNQ1OT1: a potential target in exosomes derived from adipose-derived stem cells for the treatment of osteoporosis. Stem Cells Int. 2021;2021:7690006. doi:10.1155/2021/7690006
   PubMed Web of Science ®Google Scholar
• Hu L, Guan Z, Tang C, Li G, Wen J. Exosomes derived from microRNA-21 overexpressed adipose tissue-derived mesenchymal stem cells alleviate spine osteoporosis in ankylosing spondylitis mice. J Tissue Eng Regen Med. 2022;16:634–642. doi:10.1002/term.3304
   PubMed Web of Science ®Google Scholar
• Chen M, Fu W, Xu H et al. Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Cytokine Growth Factor Rev. 2023;70:54–66. doi:10.1016/j.cytogfr.2023.03.002.
   PubMed Web of Science ®Google Scholar
• Yang RZ, Xu WN, Zheng HL, et al. Involvement of oxidative stress-induced annulus fibrosus cell and nucleus pulposus cell ferroptosis in intervertebral disc degeneration pathogenesis. J Cell Physiol. 2021;236:2725–2739. doi:10.1002/jcp.30039
   PubMed Web of Science ®Google Scholar
• Oliveira SM, Pirraco RP, Marques AP, et al. Platelet lysate-based pro-angiogenic nanocoatings. Acta Biomater. 2016;32:129–137. doi:10.1016/j.actbio.2015.12.028
   PubMed Web of Science ®Google Scholar
• Xia W, Li H, Wang Z, et al. Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int. 2011;35:639–643. doi:10.1042/CBI20100361
   PubMed Web of Science ®Google Scholar
• Zheng G, Ma HW, Xiang GH, et al. Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling. J Nanobiotechnology. 2022;20:220. doi:10.1186/s12951-022-01400-1
   PubMed Web of Science ®Google Scholar
• Kong L, Wang Y, Smith W, Hao D. Macrophages in bone homeostasis. Curr Stem Cell Res Ther. 2019;14:474–481. doi:10.2174/1574888X14666190214163815
   PubMed Web of Science ®Google Scholar
• Yu L, Hu M, Cui X, et al. M1 macrophage-derived exosomes aggravate bone loss in postmenopausal osteoporosis via a microRNA-98/DUSP1/JNK axis. Cell Biol Int. 2021;45:2452–2463. doi:10.1002/cbin.11690
   PubMed Web of Science ®Google Scholar
• Niedermair T, Lukas C, Li S, et al. Influence of extracellular vesicles isolated from osteoblasts of patients with cox-arthrosis and/or osteoporosis on metabolism and osteogenic differentiation of BMSCs. Front Bioeng Biotechnol. 2020;8:615520. doi:10.3389/fbioe.2020.615520
   PubMed Web of Science ®Google Scholar
• Lu Q, Qin H, Tan H, et al. Senescence osteoblast-derived exosome-mediated miR-139-5p regulates endothelial cell functions. Biomed Res Int. 2021;2021:5576023. doi:10.1155/2021/5576023
   PubMed Web of Science ®Google Scholar
• Omidvar MH, Soltani-Zangbar MS, Zamani M, et al. The effect of osteoporotic and non-osteoporotic individuals’ T cell-derived exosomes on osteoblast cells’ bone remodeling related genes expression and alkaline phosphatase activity. BMC Res Notes. 2022;15:272. doi:10.1186/s13104-022-06139-4
   PubMed Web of Science ®Google Scholar
• Kim DK, Bandara G, Cho YE, et al. Mastocytosis-derived extracellular vesicles deliver miR-23a and miR-30a into pre-osteoblasts and prevent osteoblastogenesis and bone formation. Nat Commun. 2021;12:2527. doi:10.1038/s41467-021-22754-4
   PubMed Web of Science ®Google Scholar
• Xiao F, Zuo B, Tao B, et al. Exosomes derived from cyclic mechanical stretch-exposed bone marrow mesenchymal stem cells inhibit RANKL-induced osteoclastogenesis through the NF-κB signaling pathway. Ann Transl Med. 2021;9:798. doi:10.21037/atm-21-1838
   PubMed Web of Science ®Google Scholar
• Song H, Li X, Zhao Z, et al. Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes. Nano Lett. 2019;19:3040–3048. doi:10.1021/acs.nanolett.9b00287
   PubMed Web of Science ®Google Scholar
• Xu R, Shen X, Si Y, et al. MicroRNA-31a-5p from aging BMSCs links bone formation and resorption in the aged bone marrow microenvironment. Aging Cell. 2018;17:e12794. doi:10.1111/acel.12794
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Q, Su H, Cheng J. Exosomes from adipose derived mesenchymal stem cells alleviate diabetic osteoporosis in rats through suppressing NLRP3 inflammasome activation in osteoclasts. J Biosci Bioeng. 2021;131:671–678. doi:10.1016/j.jbiosc.2021.02.007
   PubMed Web of Science ®Google Scholar
• Ren L, Song ZJ, Cai QW, et al. Adipose mesenchymal stem cell-derived exosomes ameliorate hypoxia/serum deprivation-induced osteocyte apoptosis and osteocyte-mediated osteoclastogenesis in vitro. Biochem Biophys Res Commun. 2019;508:138–144. doi:10.1016/j.bbrc.2018.11.109
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Q, Su H, Cheng J. Exosomes from adipose tissues derived mesenchymal stem cells overexpressing MicroRNA-146a alleviate diabetic osteoporosis in rats. Cell Mol Bioeng. 2022;15:87–97. doi:10.1007/s12195-021-00699-4
   PubMed Web of Science ®Google Scholar
• Kouakou YI, Tod M, Leboucher G, et al. Systematic review of artesunate pharmacokinetics: implication for treatment of resistant malaria. Int J Infect Dis. 2019;89:30–44. doi:10.1016/j.ijid.2019.08.030
   PubMed Web of Science ®Google Scholar
• Huang MZ, Zhuang Y, Ning X, Zhang H, Shen ZM, Shang XW. Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis. Biosci Rep. 2020;40. doi:10.1042/BSR20194387
   Web of Science ®Google Scholar
• Huang MZ, Chen HY, Peng GX, et al. Exosomes from artesunate-treated bone marrow-derived mesenchymal stem cells transferring SNHG7 to promote osteogenesis via TAF15-RUNX2 pathway. Regener Med. 2022;17:819–833. doi:10.2217/rme-2022-0065
   PubMed Web of Science ®Google Scholar
• Zhang JH, Xin HL, Xu YM, et al. Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2018;213:230–255. doi:10.1016/j.jep.2017.10.028
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang S, Jiang K, Li T, Yan C. Bioassay-guided isolation and evaluation of anti-osteoporotic polysaccharides from Morinda officinalis. J Ethnopharmacol. 2020;261:113113.
   PubMed Web of Science ®Google Scholar
• Wu P, Jiao F, Huang H, et al. Morinda officinalis polysaccharide enable suppression of osteoclastic differentiation by exosomes derived from rat mesenchymal stem cells. Pharm Biol. 2022;60:1303–1316. doi:10.1080/13880209.2022.2093385
   PubMed Web of Science ®Google Scholar
• Yun B, Maburutse BE, Kang M, et al. Short communication: dietary bovine milk-derived exosomes improve bone health in an osteoporosis-induced mouse model. J Dairy Sci. 2020;103:7752–7760. doi:10.3168/jds.2019-17501
   PubMed Web of Science ®Google Scholar
• Cui Y, Guo Y, Kong L, et al. A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioact Mater. 2022;10:207–221. doi:10.1016/j.bioactmat.2021.09.015
   PubMed Web of Science ®Google Scholar
• Hu Y, Li X, Zhang Q, et al. Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss. Bioact Mater. 2021;6:2905–2913. doi:10.1016/j.bioactmat.2021.02.014
   PubMed Web of Science ®Google Scholar